|
Organization and Summary of Significant Accounting Policies (Details Textual) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | 1 Months Ended |
|---|---|---|
|
Mar. 31, 2013
Segment
|
Dec. 31, 2012
Collaborative Arrangement, Co-promotion [Member]
|
|
| Organization and Summary of Significant Accounting Policies (Textual) [Abstract] | ||
| FDA approval milestone payment | $ 50.0 | |
| Organization and Summary of Significant Accounting Policies (Additional Textual) [Abstract] | ||
| Number of operating business segments | 1 | |
| Non-cash loss on an increase in the fair value | $ 3.0 |
| X | ||||||||||
|
- Definition
Change in fair value of warrants. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Revenue recognition using milestone method Fda approval achievement amount. No definition available.
|
| X | ||||||||||
|
- Definition
Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. No definition available.
|